abstract |
The present invention encompasses compounds of general formula (1) n n n n n n n n n n whereinn R 1 to R 3 are defined as in claim 1 , which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, and the use thereof for preparing a pharmaceutical composition having the above-mentioned properties. |